| LATEST NEWS | Global energy crisis: CAAM extends credit period for payment of fees and charges for up to 60 days effective May 1 to maintain sustainability of aviation industry operations -- Loke | RM50 flight ticket rebate for M'sians on Peninsula-Sabah, S'wak and Labuan routes in conjunction with Gawai and Kaamatan, from May 15 to June 14 — Loke | PM Anwar announces RM2 million for Malaysian Sepaktakraw Academy Complex - PM Anwar | Global energy crisis: ERL introduces MyPutrajaya Monthly Travel Card for civil servants working or residing in Putrajaya — Loke | Global energy crisis: KTMB offers 30% discount on ETS tickets for all sectors and Ekspres Rakyat Timuran service on JB Sentral-Tumpat-JB Sentral route — Loke | |
KUALA LUMPUR, June 30 (Bernama) -- Malaysia’s pharmaceutical industry is emerging as a driver of high-value investment, skilled employment, and healthcare resilience, driven by regulatory and productivity reforms implemented in recent years, according to the Malaysia Productivity Corporation (MPC).
